Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 10/20 | 0.64 |
| ▸ | THRA | P10827 | 8/20 | 0.64 |
| ▸ | PPARG | P37231 | 6/20 | 0.64 |
| ▸ | RXRA | P19793 | 3/20 | 0.64 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.64 |
| ▸ | ITGAV | P06756 | 1/20 | 0.64 |
| ▸ | TPMT | P51580 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.56 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.56 |
| ▸ | TTR | P02766 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | HTR1A | P08908 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.56 |
| ▸ | HTR2B | P41595 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11223984 | 0.85 | TPMT (0.49) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL1613916 | 0.82 | TPMT (0.68) | THRBTPMTLMNAHSD17B10MEN1 | |
| SCHEMBL12764452 | 0.82 | THRB (0.64) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL9748136 | 0.81 | THRB (0.67) | THRBTHRAPPARGRXRATPMT | |
| SCHEMBL4008454 | 0.81 | PCNA (0.61) | THRBTHRAPPARGRXRATPMT | |
| SCHEMBL16167912 | 0.80 | THRB (0.47) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL6135835 | 0.79 | TPMT (0.58) | RXRATPMTMEN1KMT2ATTR | |
| SCHEMBL6858181 | 0.79 | THRB (0.46) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL24407708 | 0.79 | PARP15 (0.55) | THRBTHRAPPARGRXRAITGB3 | |
| SCHEMBL6720943 | 0.79 | TPMT (0.50) | THRBTHRAPPARGRXRAITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805480-A | Preparation method of octreotide | 江苏金斯瑞生物科技有限公司 | 2022-07-29 | — | — | CN | claimed |
| WO-2026107381-A1 | DNA POLYMERASE THETA INHIBITORS, COMPOSITIONS THEREOF, COMPOSITIONS FURTHER COMPRISING A DNA DEPENDENT PROTEIN KINASE, AND USES OF BOTH IN GENE EDITING FIELD | JUNO THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4724443-A1 | PYRAZOLO-PYRIMIDINONE COMPOUNDS FOR USE IN METHODS OF INHIBITING WEE1 A KINASE | Acrivon Therapeutics, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| US-20260097125-A1 | ULTRA-LONG-ACTING PLATFORM COMPRISING FC-ADVANCED FATTY ACID CHAIN | WATERSTONE PHARMACEUTICALS WUHAN CO LTD (CN) | 2026-04-09 | — | — | US | disclosed |
| US-12576158-B2 | Antibody drug conjugates with cleavable linkers | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2026-03-17 | — | — | US | disclosed |
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-12 | — | — | US | disclosed |
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-01-15 | — | — | US | disclosed |
| EP-4665719-A1 | SMALL MOLECULE TREATMENT OF FATTY LIVER DISEASE AND HCC | ScandiEdge Therapeutics AB (SE) | 2025-12-24 | — | — | EP | disclosed |
| US-20220152183-A1 | CARBOCYCLIC DERIVATIVES AND CONJUGATED DERIVATIVES THEREOF, AND THEIR USE IN VACCINES | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-05-19 | — | — | US | disclosed |
| CN-112094324-B | Synthesis method of carbetocin | 宁波三生生物科技股份有限公司 | 2022-05-03 | — | — | CN | disclosed |
| EP-3972648-A1 | ANTIBODY DRUG CONJUGATES WITH CLEAVABLE LINKERS | Heidelberg Pharma Research GmbH (DE) | 2022-03-30 | — | — | EP | disclosed |
| CN-114144201-A | Antibody drug conjugates containing a cleavable linker | 海德堡医药研究有限责任公司 | 2022-03-04 | — | — | CN | disclosed |
| WO-2022043238-A1 | PENTAVALENT VACCINE AGAINST NEISSERIA MENINGITIDIS COMPRISING A SYNTHETIC MEN A ANTIGEN | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-03-03 | — | — | WO | disclosed |
| CN-114126620-A | FGFR inhibitors and methods of use thereof | 传达治疗有限公司 | 2022-03-01 | — | — | CN | disclosed |
| US-5273885-A | Using a polyiodothyronine analog of a phenyl compound containing a hydroxyl group ortho to an iodine | SYNTEX (U.S.A.) INC. (US) | 1993-12-28 | — | — | US | disclosed |
| EP-0204523-B1 | GLUCOSE-6-PHOSPHATE DEHYDROGENASE CONJUGATES, THEIR PREPARATION AND USE | SYNTEX (U.S.A.) INC. (US) | 1992-02-26 | — | — | EP | disclosed |
| US-4847195-A | IMMUNOASSAY | SYNTEX (U.S.A.) INC. (US) | 1989-07-11 | — | — | US | disclosed |
| EP-0204523-A2 | Glucose-6-phosphate dehydrogenase conjugates, their preparation and use | SYNTEX (U.S.A.) INC. (US) | 1986-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097125-A1 | ULTRA-LONG-ACTING PLATFORM COMPRISING FC-ADVANCED FATTY ACID CHAIN | FCGR2A, FCGR1A, FCGR3B | THRB 2502/4885THRA 922/4885PPARG 59/4885 |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | KLK3, BRDT, BPHL | THRB 955/4885THRA 358/4885PPARG 734/4885 |
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | NPPA, MACF1, IGF1R | THRB 651/4885THRA 39/4885PPARG 2055/4885 |
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | IAPP, NPPA, ARG1 | THRB 434/4885THRA 330/4885PPARG 1195/4885 |
| US-12576158-B2 | Antibody drug conjugates with cleavable linkers | PTMS, C3AR1, ANPEP | THRB 1161/4885THRA 1557/4885PPARG 4867/4885 |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | PAM, CRYAA, COL1A1 | THRB 2135/4885THRA 562/4885PPARG 4275/4885 |
| US-20220152183-A1 | CARBOCYCLIC DERIVATIVES AND CONJUGATED DERIVATIVES THEREOF, AND THEIR USE IN VACCINES | AADAC, NOD2, HDAC3 | THRB 4254/4885THRA 4294/4885PPARG 1719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.